UBS assumed coverage of Emerson (EMR) with a Neutral rating and price target of $135, up from $120. The firm expanded its coverage of electrical equipment and multi-industry companies to include 16 large cap stocks. UBS believes we are overdue for recovery as the ISM Manufacturing PMI has been in contraction territory for 24 consecutive months, “by far the longest stretch of contraction in the last three decades.” There is also a clear inverse relationship between industrial output and interest rates, implying potential for a positive catalyst as interest rates further normalize, the analyst tells investors in a research note. The firm adds the outcome of the recent U.S. election gives way to potential for more robust short cycle recovery.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: